## Abstract It can be difficult to clinically distinguish between classical Parkinson's disease (PD) and progressive supranuclear palsy. Previously, there have been no biomarkers that reliably allow this distinction to be made. We report that an abnormal brain iron accumulation is a marker for ongo
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease
β Scribed by Sophie Holemans; France Javoy-Agid; Yves Agid; Freddy De Paermentier; E. Christian Laterre; Jean-Marie Maloteaux
- Book ID
- 115804962
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 679 KB
- Volume
- 642
- Category
- Article
- ISSN
- 0006-8993
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The topographic distribution of brain atrophy was quantified by image analysis of fixed coronal brain slices from 12 patients dying with Huntington's disease (HD) and from 4 other patients dying with progressive supranuclear palsy (PSP). In HD, atrophy was maximal within the caudate nucleus, putamen
## Abstract Dysphagia is common in both Parkinson's disease (PD) and progressive supranuclear palsy (PSP). Although it is believed to be more common in PSP, there are no controlled data and no comparison of swallowing function between these two disorders. Our aim was to assess dysphagia and swallow